Adolescents, HIV, and PrEP

Jun 16, 2021 06:30pm -
Jun 16, 2021 08:00pm
(GMT-5)
ZOOM

Event Description

PHA MEDICAL EDUCATION

ON-DEMAND PROGRAMS

A Meeting of the New Jersey Association of Osteopathic Physicians and Surgeons

 

Adolescents, HIV, and PrEP

 

Wednesday, June 16, 2021

 

 

Presenter:

Antonio Urbina, MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai

 

Location:

 

Caffe Aldo Lamberti
2011 ROUTE 70 WEST
Cherry Hill, New Jersey 08002

 

‚Äč

LEARNING OBJECTIVES
Upon completion of this educational activity, participants should be able to:
  • Discuss communication approaches to assess sexual risk behaviors among adolescents
  • Discuss barriers to HIV testing in adolescents and starting either PrEP or ART among adolescents with HIV
  • Select PrEP and ART options according to the guideline recommendations by the Department of Health and Human Services

 

 

 

 

Supported by an independent educational grant from Gilead Sciences Medical Affairs and hosted by Simply Speaking (R) HIV Prevention CME Lecture Series.
 
TARGET AUDIENCE
This educational activity is strictly for healthcare providers who are involved in the clinical care of patients with or at increased risk for HIV, including physicians, physician assistants, registered nurses, nurse practitioners, and pharmacists, but attendance is not guaranteed.
 
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Practice Point Communications, Inc. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
PHYSICIANS/PHYSICIAN ASSISTANTS 
The University of Nebraska Medical Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
DISCLOSURE INFORMATION
It is the policy of the continuing education accreditors to ensure accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. Faculty are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
 
All faculty, planners and others in a position to control continuing education content participating in an accredited activity are required to disclose all relevant financial relationships with ineligible companies. Ineligible companies are organizations referred as commercial interests within the Standards for Integrity and Independence in Accredited Continuing Education whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited providers are responsible for mitigating all relevant financial relationships on accredited continuing education. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.
 
This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.
 
All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of the accredited providers and Practice Point Communications.
 
FACULTY AND PLANNING COMMITTEE DISCLOSURES
The accredited providers have mitigated and are disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:
 
PLANNING COMMITTEE DISCLOSURE INFORMATION
 
Nada Fadul, MD
Advisory Committee/Board: ViiV Healthcare
 
Nothing to disclose
UNMC: Valeta Creason-Wahl; Heidi Keeler, PhD, RN; Renee Paulin, MSN, RN, CWOCN; Brenda Ram, CMP, CHCP; Sara Hurtado Bares, MD
DU: Amy G. Woods, PharmD, MS Leadership
PPC: Chris Fleming; Peter Pinkowish; Kelly McCulloch
 
CONTENT DEVELOPMENT & TRAINING FACULTY DISCLOSURE INFORMATION
 
Lisa B. Hightow-Weidman, MD
Nothing to disclose
 
COPYRIGHT INFORMATION
Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:
 
The Materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
 
Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without prior written permission.
 
COMMERCIAL SUPPORT ACKNOWLEDGMENT
Supported by an independent educational grant from Gilead Sciences Medical Affairs
 
Copyright 2021 by Practice Point Communications
 
To register, please click here and use event code: HVP03203764

Event Type:Webinar
Category:Educational Seminar
Early registration ends on May 23, 2021.
Regular registration starts on May 24, 2021 and ends on Jun 16, 2021.
Late registration starts on Jun 17, 2021.
(GMT-05:00) Eastern Time (US & Canada)